| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |